Enriching digital twins of the human heart with real ion channels
Enriching digital twins of the human heart with real ion channels

Enriching digital twins of the human heart with real ion channels

A biological-digital twin enabling faster, safer prediction of genetic heart rhythm disorders and drug responses

Periode
-
Looptijd
48 months
Deel van call / Programma
/
Projectpartners
Elements
Nanion Technologies Inc.
NLHI Q8q5o31y98yaa9uassr24buf1wy5oujmv6ak9s96hk

Electrical impulses are essential for the heart to beat properly. Mutations in ion channel genes can disrupt these impulses, leading to life-threatening arrhythmias or sudden cardiac arrest. However, not every mutation is harmful, and with the rapid rise in genetic testing, clinicians face an increasing challenge: how to predict which mutations are dangerous, and which treatment will work best for each patient.

Current laboratory techniques, such as manual patch clamp electrophysiology, can answer these questions but are extremely time-consuming—often taking a team of experts a full year to study a single mutation. There is a pressing need for faster, scalable methods.

In this project, a new collaboration between De Boer, Nanion, and Elements will advance a breakthrough approach: the Excitable Biological-Digital Twin (ExBDT). This innovative technology connects living heart cells expressing ion channels to a real-time computer simulation of a human cardiac action potential. Using Nanion’s automated 384-cell patch clamp system and Elements’ high-speed electronics, biological and digital signals are linked in a closed feedback loop, creating a hybrid model that mimics the human heart’s electrical behavior with unprecedented accuracy.

The project will refine and validate this system, demonstrating its predictive value for patient-specific mutations. Deliverables include proof-of-concept experiments confirming correlation with clinical phenotypes, refined hardware and software integration, and publication of findings in peer-reviewed journals.

By combining biological realism with computational speed, ExBDT can greatly accelerate the evaluation of cardiac ion channel mutations and drug responses. This innovation could shorten diagnostic timelines from months to days, paving the way for truly personalized treatment of inherited heart rhythm disorders.

More information about Nanion Technologies

More information about Elements Srl.

More information about Heart Institute

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.